Special Issue: PANS-PANDAS Treatment Guidelines
Journal of Child and Adolescent Psychopharmacology, Volume 27, Issue 7, Mary Ann Liebert, Inc., September 2017Swedo, MD, Frankovich, MD, MS, Murphy, MD, MS
Special Issue Main Page
Full List of Articles
Overview of Treatment of Pediatric Acute-Onset Neuropsychiatric Syndrome
Swedo, MD, Frankovich, MD, MS, Murphy, MD, MS
Clinical Management of PANS
Clinical Management of PANS: Part I–Psychiatric and Behavioral Interventions
Part I—Psychiatric and Behavioral Interventions, Thienemann, MD, et al. Presents consensus guidelines for treating the psychiatric and behavioral symptoms of children with PANS/PANDAS. Symptom improvement is aimed at decreasing suffering, improving functioning, and making it easier for the children to adhere to therapeutic interventions.
Clinical Management of PANS: Part II—Use of Immunomodulatory Therapies
Part II—Use of Immunomodulatory Therapies, Frankovich, MD, et al. Provide recommendations to help guide the use of therapies targeting the neuroinflammation and post-infectious autoimmunity that are common in PANS-PANDAS.
Clinical Management of PANS: Part III—Treatment and Prevention of Infections
Part III—Treatment and Prevention of Infections, Cooperstock, MD, MPH, et al. Present a consensus guideline for managing the infection components of these neuropsychiatric conditions.
Pediatric Acute-Onset Neuropsychiatric Syndrome Response to Oral Corticosteroid Bursts: An Observational Study of Patients in an Academic Community-Based PANS Clinic, Brown, et al.
Course of Neuropsychiatric Symptoms After Introduction and Removal of Nonsteroidal Anti-Inflammatory Drugs: A Pediatric Observational Study Spartz, MD, et al
Effect of Early and Prophylactic Nonsteroidal Anti-Inflammatory Drugs on Flare Duration in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Observational Study of Patients Followed by an Academic Community-Based Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic
Brown, MD, et al